- Home
- DNLI vs QDEL Comparison
DNLI vs QDEL Comparison
Compare DNLI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- QDEL
- Stock Information
- Founded
- DNLI 2013
- QDEL 1979
- Country
- DNLI United States
- QDEL United States
- Employees
- DNLI N/A
- QDEL N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- QDEL Medical Specialities
- Sector
- DNLI Health Care
- QDEL Health Care
- Exchange
- DNLI Nasdaq
- QDEL Nasdaq
- Market Cap
- DNLI 2.1B
- QDEL 1.9B
- IPO Year
- DNLI 2017
- QDEL N/A
- Fundamental
- Price
- DNLI $15.43
- QDEL $28.68
- Analyst Decision
- DNLI Strong Buy
- QDEL Buy
- Analyst Count
- DNLI 15
- QDEL 7
- Target Price
- DNLI $33.62
- QDEL $42.57
- AVG Volume (30 Days)
- DNLI 2.0M
- QDEL 1.1M
- Earning Date
- DNLI 11-05-2025
- QDEL 08-05-2025
- Dividend Yield
- DNLI N/A
- QDEL N/A
- EPS Growth
- DNLI N/A
- QDEL N/A
- EPS
- DNLI N/A
- QDEL N/A
- Revenue
- DNLI N/A
- QDEL $2,741,600,000.00
- Revenue This Year
- DNLI N/A
- QDEL N/A
- Revenue Next Year
- DNLI $802.87
- QDEL $3.40
- P/E Ratio
- DNLI N/A
- QDEL N/A
- Revenue Growth
- DNLI N/A
- QDEL N/A
- 52 Week Low
- DNLI $10.57
- QDEL $22.05
- 52 Week High
- DNLI $33.33
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- DNLI 56.61
- QDEL 59.55
- Support Level
- DNLI $14.52
- QDEL $26.81
- Resistance Level
- DNLI $16.20
- QDEL $28.84
- Average True Range (ATR)
- DNLI 0.70
- QDEL 1.11
- MACD
- DNLI -0.01
- QDEL 0.23
- Stochastic Oscillator
- DNLI 62.44
- QDEL 85.08
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.